Immunovant Fiscal Q2 Loss Narrows-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Immunovant Fiscal Q2 Loss Narrows

Nov 10, 2025 5:03 AM

07:32 AM EST, 11/10/2025 (MT Newswires) -- Immunovant ( IMVT ) reported a fiscal Q2 net loss Monday of $0.73 per diluted share, narrower than the net loss of $0.74 a year earlier.

Analysts polled by FactSet expected a loss of $0.69.

As of Sept. 30, the company said it had $521.9 million in cash and cash equivalents, which will likely finance operations through Graves' disease trial readout anticipated in 2027.

Previous page： Rivian Secures $6.6 Billion DOE Loan for Georgia Plant Construction; Shares Rise After Hours Next page： GM agrees to 5-year ban on selling drivers' location data

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Rivian Secures $6.6 Billion DOE Loan for Georgia Plant Construction; Shares Rise After Hours

Jan 16, 2025

05:10 PM EST, 01/16/2025 (MT Newswires) -- Rivian Automotive ( RIVN ) said late Thursday it closed a loan agreement with the US Department of Energy for up to $6.6 billion to back the construction of a plant in Stanton Springs North, Georgia. The loan will be divided into two phases for Rivian's Georgia facility, with the first phase expected...

GM agrees to 5-year ban on selling drivers' location data

Jan 16, 2025

WASHINGTON, Jan 16 (Reuters) - U.S. automaker General Motors ( GM ) and its subsidiary OnStar agreed not to disclose consumers' sensitive geolocation and driver behavior data to consumer reporting agencies for five years, the U.S. Federal Trade Commission said on Thursday. The agency alleged General Motors ( GM ) collected, used, and sold drivers' precise geolocation data and driving...

Yelp Insider Sold Shares Worth $395,067, According to a Recent SEC Filing

Jan 16, 2025

05:09 PM EST, 01/16/2025 (MT Newswires) -- David A Schwarzbach, Chief Financial Officer, on January 15, 2025, sold 10,000 shares in Yelp (YELP) for $395,067. Following the Form 4 filing with the SEC, Schwarzbach has control over a total of 191,988 shares of the company, with 191,988 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1345016/000134933425000001/xslF345X05/wk-form4_1737064947.xml ...

Edwards Lifesciences Insider Sold Shares Worth $343,736, According to a Recent SEC Filing

Jan 16, 2025

05:11 PM EST, 01/16/2025 (MT Newswires) -- Donald E Bobo Jr, Corporate Vice President, Strategy and Business Development, on January 16, 2025, sold 5,000 shares in Edwards Lifesciences ( EW ) for $343,736. Following the Form 4 filing with the SEC, Bobo has control over a total of 220,704 shares of the company, with 46,936 shares held directly and 173,769...